Omada Health, Inc. (NASDAQ:OMDA) Stock Has Consensus Price Target of $26.67 According to Brokerages

Omada Health, Inc. (NASDAQ:OMDA) has been assigned an average rating of “Moderate Buy” from the fourteen analysts that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $26.67.

A number of research firms have recently weighed in on OMDA. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Robert W. Baird lifted their price target on shares of Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a report on Wednesday, August 12th. Morgan Stanley reiterated an “overweight” rating and set a $30.00 target price on shares of Omada Health in a report on Monday, June 22nd. Citizens Jmp upped their price target on shares of Omada Health from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research report on Friday, August 14th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Omada Health in a research report on Friday, September 11th.

Insider Activity

In other news, President Wei-Li Shao sold 4,036 shares of the company’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.85, for a total value of $88,186.60. Following the sale, the president owned 295,313 shares in the company, valued at approximately $6,452,589.05. This represents a 1.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Craig Gracey sold 1,042 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the transaction, the chief accounting officer owned 15,441 shares in the company, valued at $386,025. This trade represents a 6.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 122,721 shares of company stock valued at $2,843,167 in the last 90 days. Company insiders own 6.38% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of OMDA. Integrated Wealth Concepts LLC bought a new position in shares of Omada Health in the second quarter valued at approximately $53,000. Versant Capital Management Inc grew its holdings in Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after acquiring an additional 2,283 shares during the period. Legal & General Group Plc bought a new stake in Omada Health in the second quarter worth about $76,000. The Manufacturers Life Insurance Company acquired a new stake in Omada Health in the 2nd quarter valued at about $215,000. Finally, Fifth Third Bancorp bought a new position in shares of Omada Health during the 1st quarter valued at about $127,000.

Omada Health Stock Performance

Omada Health stock opened at $19.37 on Friday. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 387.40 and a beta of 1.86. The stock’s fifty day moving average is $21.84 and its two-hundred day moving average is $18.55.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, sell-side analysts forecast that Omada Health will post 0.09 EPS for the current fiscal year.

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.